JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iyer, R. A.
Right arrow Articles by Anders, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iyer, R. A.
Right arrow Articles by Anders, M. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYSTEINE

Vol. 283, Issue 3, 1544-1551, 1997

Nephrotoxicity of the Glutathione and Cysteine S-Conjugates of the Sevoflurane Degradation Product 2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A) in Male Fischer 344 Rats1

Ramaswamy A. Iyer, Raymond B. Baggs and M. W. Anders

Departments of Pharmacology and Physiology (R.A.I., M.W.A.) and of Laboratory Animal Medicine (R.B.B.), University of Rochester, Rochester, New York

2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (Compound A) is a halogenated alkene that is nephrotoxic in rats when administered by inhalation or intraperitoneally. Compound A undergoes glutathione-dependent metabolism: Compound A-derived glutathione S-conjugates and mercapturates are excreted in the bile and urine, respectively, of rats given Compound A. The present experiments were designed to study the nephrotoxicity of the Compound A-derived glutathione and cysteine S-conjugates, S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]glutathione 2, S-[2-(fluoromethoxy)-1,3,3,3-tetrafluoro-1-propenyl]glutathione 3, S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-L-cysteine 4 and S-[2-(fluoromethoxy)-1,3,3,3-tetrafluoro-1-propenyl]-L-cysteine 5. Conjugates 2, 3 and 4 given intraperitoneally produced dose-dependent nephrotoxicity that was characterized by diuresis, increased excretion of glucose and protein, elevated blood urea nitrogen concentrations and severe morphological changes in the kidneys, particularly in the proximal tubules. Glutathione S-conjugate 2, at a dose of 500 µmol/kg, was hepatotoxic. Cysteine S-conjugate 5 was not nephrotoxic, apparently because of its facile cyclization to the thiazoline 2-[1-(fluoromethoxy)-2,2,2-trifluoroethyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid, which is not a beta -lyase substrate. Also, the alpha -methyl analog of cysteine S-conjugate 4 S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-DL-alpha -methylcysteine, which cannot undergo beta -lyase-dependent bioactivation, was not nephrotoxic. These in vivo data show that Compound A-derived S-conjugates are nephrotoxic and that the toxicity is associated with beta -lyase-dependent bioactivation.


0022-3565/97/2833-1544$03.00/0
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
E. D. Kharasch, J. L. Schroeder, T. Bammler, R. Beyer, and S. Srinouanprachanh
Gene Expression Profiling of Nephrotoxicity from the Sevoflurane Degradation Product Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl Ether ("Compound A") in Rats
Toxicol. Sci., April 1, 2006; 90(2): 419 - 431.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. G. Altuntas and E. D. Kharasch
Biotransformation of L-Cysteine S-Conjugates and N-Acetyl-L-Cysteine S-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability in N-Acetylation, N-Deacetylation, and beta -Lyase-Catalyzed Metabolism
Drug Metab. Dispos., February 1, 2002; 30(2): 148 - 154.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. D. Kharasch, E. J. Frink Jr., A. Artru, P. Michalowski, G. A. Rooke, and W. Nogami
Long-Duration Low-Flow Sevoflurane and Isoflurane Effects on Postoperative Renal and Hepatic Function
Anesth. Analg., December 1, 2001; 93(6): 1511 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Kraus, V. Uttamsingh, M.W. Anders, and S. Wolf
Porcine Kidney Microsomal Cysteine S-Conjugate N-Acetyltransferase-Catalyzed N-Acetylation of Haloalkene-Derived Cysteine S-Conjugates
Drug Metab. Dispos., April 1, 2000; 28(4): 440 - 445.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
R. I. Mazze, C. M. Callan, S. T. Galvez, L. Delgado-Herrera, and D. B. Mayer
The Effects of Sevoflurane on Serum Creatinine and Blood Urea Nitrogen Concentrations: A Retrospective, Twenty-Two-Center, Comparative Evaluation of Renal Function in Adult Surgical Patients
Anesth. Analg., March 1, 2000; 90(3): 683 - 688.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.